1 1 那彦群,叶章群,孙颖浩等主编.中国泌尿外科疾病诊断治疗指南2014版[S],北京:人民卫生出版社,2013. 2 2 吴阶平.吴阶平泌尿外科学〔M〕.济南:山东科技出版社.2004.5. 3 3 Center MM,Jemal A,Lortet-Tieulent J , et al .International variation in prostate cancer incidence and mortality rates〔J〕. European urology,2012,61:1079-1092. 4 4 鲍萍萍,彭萍.中国2008年前列腺癌发病率、死亡和患病情况的估计及预测〔J〕.中华流行病学杂志,2012,33:1056-1059. 5 5 林尤斌.前列腺癌筛查在健康体检人群中的应用价值〔J〕.中国实验诊断学,2012,6:1457-1459. 6 6 Greene KL,Albertsen PC,Babaian RJ, et al .Prostate specific antigen best practice statement: 2009 update〔J〕.Urol,2009,182:2232-41. 7 7 Wolf AM,Wender RC,Etzioni RB, et al .American Cancer Society Prostate Cancer Advisory Committee. American Cancer Society guideline for the early detection of prostate cancer: update2010〔J〕.CA Cancer J Clin,2010,60:70-98. 8 8 Amir Qaseem MD,Michael J,Barry MD, et al .Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians〔J〕.Ann Intern Med,2013,158:761-769. 9 9 华立新,乔迪,宋宁宏,等. 应用前列腺特异抗原筛查诊断前列腺癌的临床意义〔J〕.中华肿瘤杂志,2009,31:705-709. 10 10 Schröder FH,Hugosson J,Roobol MJ, et al . ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study〔J〕.N Engl J Med,2009,360:1320-1328. 11 11 王丽,俞容,贺青,等.新疆维族与汉族前列腺疾病患者PSA系列水平的差异性研究〔J〕.西部医学,2012,24:346-349. 12 12 热依汗,杨恺,杨忠礼,等.维族和汉族前列腺癌患者PSA与激素水平的差异性研究〔J〕.临床检验杂志,2008,26:214-232. 13 13 刘明,王建业,朱玲,等.中老年男性人群年龄与前列腺特异抗原水平的关系〔J〕.中华老年医学杂志,2010,29:999-1001. 14 14 顾苗根,张志根,吴群华.患者年龄和前列腺体积与PSA的关系〔J〕.临床泌尿外科杂志,2001,16:6-7. 15 15 刘妮妮,徐 菲.青岛市310名师职以上干部tPSA检测结果分析〔J〕. 检验医学与临床,2013,21:2840-2841. 16 16 刘建平,梁胜军,王永忠,等.PSA对社区老年男性前列腺癌筛查的临床意义和分析〔J〕. 广州医学院学报,2010,5:51-53.